Testing a new treatment for diabetic foot ulcers
Treatments studied
Part of Hormones & metabolism, Skin clinical trials.
This trial tests a new treatment for foot ulcers caused by poor blood flow and diabetes. It compares the new treatment to a placebo (an inactive substance) to see if it helps ulcers heal better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have type 1 or type 2 diabetes.
- You have a foot ulcer that has not healed after at least a month of standard care.
- The ulcer is on your foot (not on the heel) and is not too deep or infected.
- You have no plans to have the foot amputated right now.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a special treatment (cellular acellular and matrix-like products) to standard wound care helps diabetic foot ulcers and venous leg ulcers heal faster. It may be an option if you have a diabetes-related foot ulcer that hasn't healed with standard care.
This trial compares several advanced wound treatments (called CAMPs) plus standard care versus standard care alone for diabetic foot ulcers that are slow to heal. The goal is to see if adding these treatments helps ulcers close faster.
This study tests a new wound therapy for diabetic foot ulcers that haven't healed with standard care. It aims to see if the therapy helps these ulcers heal better and faster.
This trial tests a new wound covering called NeoThelium FT to help diabetic foot ulcers heal. It is for people whose ulcer has not improved much with standard care and is not infected or too deep.
This trial tests if adding a special placenta-based wound covering to standard care helps heal diabetic foot ulcers and venous leg ulcers faster. It's for people with wounds that haven't healed after standard treatment for at least 4 weeks.
This trial tests a new cell treatment for diabetic foot ulcers by injecting special regulatory monocytes (OPM cells) to help heal wounds. It is for patients with mild to moderate ulcers that haven't healed for over a month.
Hear when a new Ulcer Foot trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.